Azitra Inc (AZTR)

May 28, 2025, 8:33 AM EDT - 9 days ago

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

May 14, 2025, 4:05 PM EDT - 23 days ago

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

May 13, 2025, 5:06 PM EDT - 24 days ago

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

Apr 25, 2025, 8:33 AM EDT - 6 weeks ago

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Apr 24, 2025, 4:05 PM EDT - 6 weeks ago

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Mar 12, 2025, 8:33 AM EDT - 3 months ago

Azitra to Present at Microbiome Times Partnering Forum

Feb 24, 2025, 8:30 AM EST - 3 months ago

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Feb 4, 2025, 2:20 PM EST - 4 months ago

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Feb 3, 2025, 9:05 AM EST - 4 months ago

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Jan 27, 2025, 4:05 PM EST - 4 months ago

Azitra, Inc. to Present at The Microcap Conference

Jan 15, 2025, 8:30 AM EST - 5 months ago

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Jan 14, 2025, 4:05 PM EST - 5 months ago

Azitra Announces Proposed Public Offering of Common Stock

Nov 12, 2024, 5:05 PM EST - 7 months ago

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Oct 29, 2024, 9:00 AM EDT - 7 months ago

Azitra to Present at BIO-Europe 2024

Oct 11, 2024, 9:00 AM EDT - 8 months ago

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 24, 2024, 8:00 AM EDT - 9 months ago

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Sep 18, 2024, 9:00 AM EDT - 9 months ago

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Sep 6, 2024, 4:30 PM EDT - 9 months ago

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 28, 2024, 8:30 AM EDT - 10 months ago

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 22, 2024, 9:00 AM EDT - 10 months ago

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Aug 20, 2024, 4:15 PM EDT - 10 months ago

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 12, 2024, 6:23 PM EDT - 10 months ago

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

Jul 25, 2024, 5:57 PM EDT - 11 months ago

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

Jul 25, 2024, 1:54 PM EDT - 11 months ago

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

HAL

Jul 25, 2024, 1:13 PM EDT - 11 months ago

Wingspire Equipment Finance's $12 Million Funding Initiative to Propel Tier 1 Aerospace Manufacturer Capabilities

HAL

Jul 23, 2024, 9:20 PM EDT - 11 months ago

Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

Jul 23, 2024, 8:00 AM EDT - 11 months ago

Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents

Jun 27, 2024, 4:05 PM EDT - 1 year ago

Azitra, Inc. Announces Reverse Stock Split

May 31, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

May 17, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

May 10, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

May 9, 2024, 5:00 PM EDT - 1 year ago

Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates

Apr 22, 2024, 4:30 PM EDT - 1 year ago

Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting

Apr 18, 2024, 4:15 PM EDT - 1 year ago

Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024

Mar 15, 2024, 4:15 PM EDT - 1 year ago

Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates

Feb 16, 2024, 4:05 PM EST - 1 year ago

Azitra, Inc. Announces Closing of Public Offering

Feb 13, 2024, 10:09 PM EST - 1 year ago

Azitra, Inc. Announces Pricing of Public Offering

Jan 16, 2024, 9:00 AM EST - 1 year ago

Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US

Jan 3, 2024, 9:00 AM EST - 1 year ago

Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference

Nov 14, 2023, 4:30 PM EST - 1 year ago

Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates

Oct 16, 2023, 8:00 AM EDT - 1 year ago

Azitra to Present at the ThinkEquity Conference

Aug 29, 2023, 8:00 AM EDT - 1 year ago

Azitra to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 14, 2023, 4:05 PM EDT - 1 year ago

Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates

Jul 19, 2023, 4:05 PM EDT - 2 years ago

Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors

Jul 11, 2023, 4:05 PM EDT - 2 years ago

Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer

Jun 21, 2023, 6:46 PM EDT - 2 years ago

Azitra, Inc. Announces Closing of Initial Public Offering

Jun 15, 2023, 7:04 PM EDT - 2 years ago

Azitra, Inc. Announces Pricing of Initial Public Offering

Jun 10, 2023, 5:30 AM EDT - 2 years ago

U.S. IPO Weekly Recap: No IPOs, But The Pipeline Gets A Pickup With 3 New Filers

BOF CAVA PXDT SRFM

May 21, 2023, 11:14 AM EDT - 2 years ago

U.S. IPO Weekly Recap: Atmus Launches $275 Million IPO And Restaurant Chain CAVA Joins The Pipeline

ATMU CWD IPO IPOS CAVA

May 14, 2023, 7:00 AM EDT - 2 years ago

U.S. IPO Weekly Recap: Pipeline News Disrupts An Otherwise Silent Week For The IPO Market

ABNB IPO IPOS SNOW VFS